Sign Up to like & get
recommendations!
0
Published in 2018 at "International Immunopharmacology"
DOI: 10.1016/j.intimp.2018.04.015
Abstract: ABSTRACT Growing evidence indicates that the Toll‐like receptor7/8(TLR7/8) agonist resiquimod (R848) is a potential inhibitor of type‐2 immunity. However, the mechanisms mediating its therapeutic effects are not fully understood. This study investigated the effects of…
read more here.
Keywords:
allergic rhinitis;
tim1 tim3;
nasal mucosa;
induced allergic ... See more keywords